LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China
· Delayed Price · Currency is CNY 18.61
-0.77 (-3.97%)
May 22, 2025, 3:00 PM CST
SHA:603883 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 22,109 | 22,213 | 22,288 | 20,055 | 15,579 | 13,867 | Upgrade
|
| Other Revenue | 144.48 | 144.48 | 149.26 | 120.29 | 117.11 | 99.9 | Upgrade
|
| Revenue | 22,254 | 22,358 | 22,437 | 20,176 | 15,696 | 13,967 | Upgrade
|
| Revenue Growth (YoY) | -1.25% | -0.36% | 11.21% | 28.54% | 12.38% | 19.75% | Upgrade
|
| Cost of Revenue | 14,932 | 14,946 | 15,157 | 13,751 | 10,659 | 9,506 | Upgrade
|
| Gross Profit | 7,322 | 7,412 | 7,280 | 6,425 | 5,037 | 4,461 | Upgrade
|
| Selling, General & Admin | 6,209 | 6,205 | 5,753 | 5,005 | 3,990 | 3,483 | Upgrade
|
| Research & Development | 10.22 | 2.01 | 2.51 | 2.23 | - | 0.15 | Upgrade
|
| Other Operating Expenses | 33.9 | 33.68 | 46.21 | 38.51 | 14.95 | 43.66 | Upgrade
|
| Operating Expenses | 6,259 | 6,247 | 5,811 | 5,053 | 4,010 | 3,536 | Upgrade
|
| Operating Income | 1,063 | 1,165 | 1,469 | 1,371 | 1,027 | 924.58 | Upgrade
|
| Interest Expense | -173.54 | -178.25 | -185.6 | -232.14 | -192.13 | -58.49 | Upgrade
|
| Interest & Investment Income | 23.6 | 22.83 | 93.87 | 51.35 | 37.14 | 20.77 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.25 | -1.25 | -5.22 | -16.91 | 4.8 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -11.6 | -13.65 | -14.61 | -13.4 | -14.44 | -27.93 | Upgrade
|
| EBT Excluding Unusual Items | 900.13 | 994.5 | 1,357 | 1,160 | 861.9 | 858.93 | Upgrade
|
| Impairment of Goodwill | -107.54 | -107.54 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -1.5 | 5.77 | 10.47 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -6.78 | -4.53 | 5.51 | 1.44 | 4.66 | -1.43 | Upgrade
|
| Asset Writedown | 0.14 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | 35.63 | 33.54 | 46.69 | 40.21 | 84.95 | 99.37 | Upgrade
|
| Pretax Income | 821.57 | 915.97 | 1,408 | 1,208 | 961.99 | 956.86 | Upgrade
|
| Income Tax Expense | 215.01 | 230.85 | 284.27 | 231.37 | 175.26 | 192.38 | Upgrade
|
| Earnings From Continuing Operations | 606.56 | 685.12 | 1,124 | 976.24 | 786.73 | 764.48 | Upgrade
|
| Minority Interest in Earnings | -158.12 | -166.05 | -194.54 | -191.28 | -117.49 | -143.39 | Upgrade
|
| Net Income | 448.44 | 519.06 | 929.02 | 784.96 | 669.24 | 621.09 | Upgrade
|
| Net Income to Common | 448.44 | 519.06 | 929.02 | 784.96 | 669.24 | 621.09 | Upgrade
|
| Net Income Growth | -53.24% | -44.13% | 18.35% | 17.29% | 7.75% | 22.09% | Upgrade
|
| Shares Outstanding (Basic) | 762 | 763 | 755 | 750 | 707 | 682 | Upgrade
|
| Shares Outstanding (Diluted) | 762 | 763 | 755 | 750 | 707 | 691 | Upgrade
|
| Shares Change (YoY) | 0.64% | 1.06% | 0.67% | 6.08% | 2.42% | 1.21% | Upgrade
|
| EPS (Basic) | 0.59 | 0.68 | 1.23 | 1.05 | 0.95 | 0.91 | Upgrade
|
| EPS (Diluted) | 0.59 | 0.68 | 1.23 | 1.05 | 0.95 | 0.90 | Upgrade
|
| EPS Growth | -53.53% | -44.71% | 17.57% | 10.57% | 5.20% | 20.63% | Upgrade
|
| Free Cash Flow | 1,898 | 1,519 | 2,109 | 2,006 | 1,820 | 1,053 | Upgrade
|
| Free Cash Flow Per Share | 2.49 | 1.99 | 2.79 | 2.67 | 2.57 | 1.52 | Upgrade
|
| Dividend Per Share | 0.411 | 0.411 | 0.508 | 0.385 | 0.296 | 0.207 | Upgrade
|
| Dividend Growth | -19.11% | -19.11% | 32.01% | 30.02% | 42.83% | 16.68% | Upgrade
|
| Gross Margin | 32.90% | 33.15% | 32.45% | 31.84% | 32.09% | 31.94% | Upgrade
|
| Operating Margin | 4.78% | 5.21% | 6.55% | 6.80% | 6.54% | 6.62% | Upgrade
|
| Profit Margin | 2.02% | 2.32% | 4.14% | 3.89% | 4.26% | 4.45% | Upgrade
|
| Free Cash Flow Margin | 8.53% | 6.79% | 9.40% | 9.94% | 11.59% | 7.54% | Upgrade
|
| EBITDA | 1,239 | 1,345 | 1,662 | 1,533 | 1,162 | 1,037 | Upgrade
|
| EBITDA Margin | 5.57% | 6.01% | 7.41% | 7.60% | 7.41% | 7.42% | Upgrade
|
| D&A For EBITDA | 176.38 | 179.84 | 193.69 | 161.87 | 135.67 | 112.02 | Upgrade
|
| EBIT | 1,063 | 1,165 | 1,469 | 1,371 | 1,027 | 924.58 | Upgrade
|
| EBIT Margin | 4.78% | 5.21% | 6.55% | 6.80% | 6.54% | 6.62% | Upgrade
|
| Effective Tax Rate | 26.17% | 25.20% | 20.19% | 19.16% | 18.22% | 20.11% | Upgrade
|
| Revenue as Reported | 22,254 | 22,358 | 22,437 | 20,176 | 15,696 | 13,967 | Upgrade
|
| Advertising Expenses | - | 115.57 | 117.99 | 94.5 | 109.84 | 103.68 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.